Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check8 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check29 days agoChange DetectedThe website has updated the intervention details, confirming the status as 'Not yet recruiting' and revising the contact information, while removing previous contact details and the earlier revision number.SummaryDifference2%
- Check58 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who to contact for questions about joining the study and where it is taking place, with a revision from v2.12.2 to v2.13.2.SummaryDifference3%
Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.